Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark

Gisela Hostenkamp, Katharina Elisabeth Fischer and Knut Borch-Johnsen
Authors registered in the RePEc Author Service: Katharina Elisabeth Blankart

Health Policy, 2016, vol. 120, issue 12, 1404-1411

Abstract: To analyse the impact of drug safety warnings from the European Medicines Agency (EMA) on drug utilisation and their interaction with information released through national reimbursement bodies.

Keywords: Drug safety warnings; Utilisation; Regulation; Post-marketing surveillance; Denmark; Germany (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851016302664
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:120:y:2016:i:12:p:1404-1411

DOI: 10.1016/j.healthpol.2016.09.020

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().